Intrathecal Dexmedetomidine Allows Reduction Of The Dose Of Hyperbaric Bupivacaine For Patients Undergoing Lower Limb Orthopedic Surgery: Prospective Case-Control Comparative Study.
Ayaad, M., Osman, H., Eissa, M. (2025). Intrathecal Dexmedetomidine Allows Reduction Of The Dose Of Hyperbaric Bupivacaine For Patients Undergoing Lower Limb Orthopedic Surgery: Prospective Case-Control Comparative Study.. EKB Journal Management System, 41(1), 1-8. doi: 10.21608/egja.2025.386326.1088
Mohamed G Ayaad; Haitham AM. Osman; Mohsen M. Eissa. "Intrathecal Dexmedetomidine Allows Reduction Of The Dose Of Hyperbaric Bupivacaine For Patients Undergoing Lower Limb Orthopedic Surgery: Prospective Case-Control Comparative Study.". EKB Journal Management System, 41, 1, 2025, 1-8. doi: 10.21608/egja.2025.386326.1088
Ayaad, M., Osman, H., Eissa, M. (2025). 'Intrathecal Dexmedetomidine Allows Reduction Of The Dose Of Hyperbaric Bupivacaine For Patients Undergoing Lower Limb Orthopedic Surgery: Prospective Case-Control Comparative Study.', EKB Journal Management System, 41(1), pp. 1-8. doi: 10.21608/egja.2025.386326.1088
Ayaad, M., Osman, H., Eissa, M. Intrathecal Dexmedetomidine Allows Reduction Of The Dose Of Hyperbaric Bupivacaine For Patients Undergoing Lower Limb Orthopedic Surgery: Prospective Case-Control Comparative Study.. EKB Journal Management System, 2025; 41(1): 1-8. doi: 10.21608/egja.2025.386326.1088